AIP
CRVO icon

Ameritas Investment Partners’s CervoMed CRVO Stock Holding History

Ameritas Investment Partners’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-529
Closed -$4.84K – 3232
2025
Q1 		$4.84K Hold
529
– – ﹤0.01% 2976
2024
Q4 		$1.24K Hold
529
– – ﹤0.01% 3113
2024
Q3 		$7.72K Hold
529
– – ﹤0.01% 2982
2024
Q2 		$9.06K Buy
+529
New +$11.6K ﹤0.01% 2957

Other funds holding CRVO

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
AAS
Avantax Advisory Services Dallas, Texas $18.2B AUM 15.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameritas Investment Partners's CRVO Position: Q2 2025 in Review

Ameritas Investment Partners sold out of CervoMed (CRVO) in Q2 2025, closing a stake of 529 shares — an estimated $4.84K sold.

Ameritas Investment Partners first reported a position in CRVO in Q2 2024 and held it in 4 quarters. The position peaked at $9.06K in Q2 2024. 45 funds tracked by Wall St. Rank hold CRVO as of Q2 2025.

  • Ameritas Investment Partners reported no remaining CervoMed position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 529 CervoMed shares in Q2 2025, an estimated $4.84K.
  • Ameritas Investment Partners first reported a position in CervoMed in Q2 2024 and held it in 4 quarters.
  • Ameritas Investment Partners's CervoMed position peaked at $9.06K in Q2 2024.
  • 45 funds tracked by Wall St. Rank held CervoMed as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.